Evaluation of genotoxic, mutagenic and antitumor properties of 2-amino-2-thiazoline, L-thioproline and 2-amino-2-thiazoline ε-formylaminocaproate

Acta Biologica Hungarica

Volumn 49, Issue 1, 1998, Pages 103-111

  Šimkevičiene, Vitalija ^a   Straukas, J ^a   Chaustova, Larisa ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

2 amino 2 thiazoline; 2 amino 2 thiazoline formylaminocaproate; Antitumor activity; Genotoxicity; L thioproline; Mutagenicity

Indexed keywords

EID: 18844382709     PISSN: 02365383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Benvenuti, S., Severi, F., Sacchetti, A., Melegari, M., Vampa, G. (1997) Synthesis, antimicrobial and genotoxic properties of some benzoimidazole derivatives. Il Farmaco 52, 231-235.
2. Brugarolas, A., Gosálvez, M. (1980) Treatment of cancer by an inducer of reverse transformation. Lancet 1, 68-70.
3. Colowick, S. P., Kaplan, N. O. (1970) Methods in Enzimology. New York-London, pp. 651.
4. De Flora, S., De Renzi, G. P. Camoirano, A., Astengo, M., Basso, C., Zanacchi, P., Bennicelli, C. (1985) Genotoxicity assay of oil dispersants in bacteria (mutation, differential lethality, SOS DNA-repair) and yeast (mitotic crossing-over). Mutation Res. 158, 19-30.
5. Diaz-Gil, J. J., Gosálvez, M. (1981) Reverse transformation of HeLa cells by 2-amino-2-thiazoline HCl, an analogous of thioproline. Proc. AACR and ASCO 22, 52.
6. European Convention for the Protection of Vertebrate Animals for Experimental and Other Scientific Purposes, Strasbourg. Council Directive (86/609/EEC), 1986.
7. Fleknell, P. A. (1966) Laboratory Animals Anasthesia. Academic. Press, 2nd ed.
8. Gabriel, S. (1889) Zur Kenntniss des Bromäthylamins. Ber. 22, 1139-1154.
9. Garofalo, A., Balconi, G., Botta, M., Corelli, F., D'Incalci, M., Fabrizi, G., Fiorini, I., Lambia, D., Nacci, V. (1993) Thioanalogues of anti-tumor antibiotics. 2. Synthesis and preliminary in vitro cytotoxicity evaluation of tricyclic [1,4] benzothiazepine derivatives. Eur. J. Med. Chem. 28, 213-220.
10. Gosálvez, M. (1979) The plasma membrane as a target in anticancer chemotherapy. Proc. AACR and ASCO 20, 17.
11. Gosálvez, M. (1980) Norgamem and revercan. The first two inducers of reverse transformation (transrecers) in anticancer therapy. Proc. AACR and ASCO. 21, 132.
12. Gosálvez, M., Vivero, C., Alvarez, J. (1979) Restoration of contact inhibition in tumour cells in tissue culture by treatment with thiazolidine-4-carboxylic acid. Biochem. Soc. Trans. 7, 191-192.
13. Kaverzneva, E. D. (1971) Applied Biochemistry and Microbiology. Moscow, 2nd ed., p. 225.
14. Killbey, B. J., Legator, M., Nichols, W., Ramel, C. (1984) Handbook of Mutagenicity. Test Procedures. Amsterdam-New York-Oxford, pp. 1-13.
15. Litchfield, J. T., Wilcoxon, F. (1949) A simplified method of evaluating dose-effects experiments. J. Phannacol. Exp. Ther. 96, 99-113.
16. Mamber, S. W., Bryson, V., Katz S. E. (1983) The Escherichia coli WP2/WP100 rec assay for detection of potential chemical carcinogens. Mutation Res. 119, 135-144.
17. Maniatis, T., Fritsch, E. F., Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, N.Y.
18. Maron, D. M., Ames, B. N. (1983) Revised methods for the Salmonella mutagenicity test. Mutation Res. 113, 173-215.
19. Opdenakker, G., Paemen, L., Norga, K., Masure, S. (1997) Proteinase inhibition in invasive cancer therapy: four control levels of matrix degradation. Int. J. Cancer. 70, 628-630.
20. Parks, R. C., Jones, T., Banks, A. R., Hessek, E. (1982) Thioproline: an inhibitor of chemical carcinogenesis. Neoplasma 29, 535-537.
21. Pine, M. J., Mirand, E. A., Ambrus, J. L., Bock, F. G. (1983) Antitumor studies of 2-amino-2-thiazoline and other tumor-modifying agents. J. Med. 14, 433-449.
22. Pizzocheri, F., Zaninelli, B. (1990) Safety test for the notification of new chemicals: EEC directive 79/831. Ivrea, Italy.
23. Ratner, S., Clarke H. T. (1937) The action of formaldehyde upon cysteine. J. Am. Chem. Soc. 59, 200-206.
24. Straukas, J., Dirvianskyte, N., Jankauskas, R., Yavorovskaja, V. E., Yevstropov, A. N., Kiseliova, V. N. (1996) Synthesis and antiviral activity of N- and O-substituted amino acids. Khim.-Farm. Zh. 30, 18-21 (in Russian).
25. Šimkevičienė, V., Straukas, J. (1997) The experimental study in chemoprevention of cancer with 2-amino-2-thiazoline ε-formylaminocaproate. 1st Int. Congr. of Asia Pacific Ass. of Med. Toxicology and the 5th Iranian Congr. of Toxicology and Poisoning. Teheran, Iran, p. 176.
26. Sandoe, P., Crips, R., Holtung, N. (1966) Animal Ethics. Report. Univ. Copenhagen, pp. 1-20.
27. Sofiina, Z., Syrkin, A., Goldin, A., Kline, A. (1980) Experimental Evaluation of Snti-tumor Drugs in the USSR and in the USA. Meditsina, Moskva (in Russian).
28. Department of Health and Human Services. Guide for the Care and Use of Laboratory Animals. Bethesda, 1985.
29. Wakabayashi, K., Nagao, M., Sugimura, T. (1992) Heterocyclic amines, lipophilic ascorbic acid, and thioproline: ubiquitous carcinogens and practical anticarcinogenic substances. In: Wattenberger, L. W. (ed.) Cancer Chemoprevention. CRC: Boca Raton, Fla. pp. 311-325.